You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Nov 10, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Nov 9, 2026
Public filing date
Nov 10, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$582.46
Nov 9, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000184
Filing cohort
Transactions in this filing
Showing 15 of 26
Trades
26
Issuers
1
Estimated value
$5.63M
Buys / sales
0 / 24
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $39.75K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $136.61K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $69.29K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $302.39K |
| United Therapeutics Corp UTHR Current | Exercise | Nov 9, 2026 | $0 |
| United Therapeutics Corp UTHR | Exercise | Nov 9, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $44.52K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $89.85K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $287.92K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $163.98K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $1.01M |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $93.86K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $290.11K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $90.3K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $124.42K |